alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,
BMS 181100,
BMS-181100,
BMY 14802,
BMY 14802-1,
BMY-14802,
BMY 14802 hydrochloride,
105565-55-7,
BMY-14802-1,
bmy-14802 hydrochloride,
1-(4-Fluorophenyl)-4-(4-(5-fluoropyrimidin-2-yl)piperazin-1-yl)butan-1-ol hydrochloride;1-(4-Fluorophenyl)-4-(4-(5-fluoropyrimidin-2-yl)piperazin-1-yl)butan-1-ol hydrochloride,
BMS-181100,
BMY 14802 HCl,
NIBVEFRJDFVQLM-UHFFFAOYSA-N,
Bmy 14802-1,
AC1MJ6BV,
SCHEMBL466842,
CTK8G5078,
AKOS024456598,
SR-01000597742,
SR-01000597742-1,
1-(4-fluorophenyl)-4-[4-(5-fluoropyrimidin-2-yl)piperazin-1-yl]butan-1-ol hydrochloride,
1-Piperazinebutanol, alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-, monohydrochloride,
ALPHA-(4-FLUOROPHENYL)-4-(5-FLUORO-2-PYRIMIDINYL)-1-PIPERAZINEBUTANOL HYDROCHLORIDE,
1-(4-fluorophenyl)-4-(4-(5-fluoro-2-pyrimidinyl)-1-piperazinyl)-1-butanol monohydrochloride,
C18H22F2N4O.ClH,
UNII-14F9C3J43Y,
Bmy-14802,
14F9C3J43Y,
C18-H22-F2-N4-O.Cl-H,
CID3086514,
105565-55-7 (HCl),
?-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol hydrochloride,